TNFRSF14 and bladder transitional cell carcinoma: These results show that high tumor expression of transcripts encoding the NK cell receptors KLRK1, TNFRSF14, and CD160 may be critical for antitumor immunity in BLCA because the expression of these receptors is associated with the IL2NK cell phenotype and a more favorable BLCA prognosis.